Global Companion Diagnostic Technologies Market Size, Status and Forecast 2019-2025

Global Companion Diagnostic Technologies market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by Marketintelligencedata Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Companion Diagnostic Technologies to 2023 offers detailed coverage of guanidine Companion Diagnostic Technologies industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Companion Diagnostic Technologies producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Companion Diagnostic Technologies Product details, including pictures and technical specifications
  • Companion Diagnostic Technologies manufacturers, distributors and channels
  • Major players present in the Companion Diagnostic Technologies
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Dako (Agilent Technologies)
  • Qiagen
  • Roche
  • Abbott Laboratories
  • Ventana Medical Systems
  • bioMerieux
  • Myriad Genetics
  • Resonance Health Ltd.
  • Leica Microsystems
  • Life Technologies

Key regions:

United States, Europe, China, Japan, Southeast Asia, India, Central & South America

Additionally, the market is segmented by the following sectors

  • Immunohistochemistry
  • Molecular Diagnostics

Not only this, figures covering the end user applications are also provided according to the following classification

  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Auto immune & Inflammation
  • Virology
  • Others

In summary, the report serves to study and analyse the Companion Diagnostic Technologies size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Companion Diagnostic Technologies, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Report Overview
    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Immunohistochemistry
      • 1.4.3 Molecular Diagnostics
    • 1.5 Market by Application
      • 1.5.1 Global Companion Diagnostic Technologies Market Share by Application (2014-2025)
      • 1.5.2 Oncology
      • 1.5.3 Cardiovascular
      • 1.5.4 Central Nervous System
      • 1.5.5 Auto immune & Inflammation
      • 1.5.6 Virology
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Global Growth Trends
    • 2.1 Companion Diagnostic Technologies Market Size
    • 2.2 Companion Diagnostic Technologies Growth Trends by Regions
      • 2.2.1 Companion Diagnostic Technologies Market Size by Regions (2014-2025)
      • 2.2.2 Companion Diagnostic Technologies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities
  • 3 Market Share by Key Players
    • 3.1 Companion Diagnostic Technologies Market Size by Manufacturers
      • 3.1.1 Global Companion Diagnostic Technologies Revenue by Manufacturers (2014-2018)
      • 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Manufacturers (2014-2018)
      • 3.1.3 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Companion Diagnostic Technologies Key Players Head office and Area Served
    • 3.3 Key Players Companion Diagnostic Technologies Product/Solution/Service
    • 3.4 Date of Enter into Companion Diagnostic Technologies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Type and Application
    • 4.1 Global Companion Diagnostic Technologies Market Size by Type (2014-2019)
    • 4.2 Global Companion Diagnostic Technologies Market Size by Application (2014-2019)
  • 5 United States
    • 5.1 United States Companion Diagnostic Technologies Market Size (2014-2019)
    • 5.2 Companion Diagnostic Technologies Key Players in United States
    • 5.3 United States Companion Diagnostic Technologies Market Size by Type
    • 5.4 United States Companion Diagnostic Technologies Market Size by Application
  • 6 Europe
    • 6.1 Europe Companion Diagnostic Technologies Market Size (2014-2019)
    • 6.2 Companion Diagnostic Technologies Key Players in Europe
    • 6.3 Europe Companion Diagnostic Technologies Market Size by Type
    • 6.4 Europe Companion Diagnostic Technologies Market Size by Application
  • 7 China
    • 7.1 China Companion Diagnostic Technologies Market Size (2014-2019)
    • 7.2 Companion Diagnostic Technologies Key Players in China
    • 7.3 China Companion Diagnostic Technologies Market Size by Type
    • 7.4 China Companion Diagnostic Technologies Market Size by Application
  • 8 Japan
    • 8.1 Japan Companion Diagnostic Technologies Market Size (2014-2019)
    • 8.2 Companion Diagnostic Technologies Key Players in Japan
    • 8.3 Japan Companion Diagnostic Technologies Market Size by Type
    • 8.4 Japan Companion Diagnostic Technologies Market Size by Application
  • 9 Southeast Asia
    • 9.1 Southeast Asia Companion Diagnostic Technologies Market Size (2014-2019)
    • 9.2 Companion Diagnostic Technologies Key Players in Southeast Asia
    • 9.3 Southeast Asia Companion Diagnostic Technologies Market Size by Type
    • 9.4 Southeast Asia Companion Diagnostic Technologies Market Size by Application
  • 10 India
    • 10.1 India Companion Diagnostic Technologies Market Size (2014-2019)
    • 10.2 Companion Diagnostic Technologies Key Players in India
    • 10.3 India Companion Diagnostic Technologies Market Size by Type
    • 10.4 India Companion Diagnostic Technologies Market Size by Application
  • 11 Central & South America
    • 11.1 Central & South America Companion Diagnostic Technologies Market Size (2014-2019)
    • 11.2 Companion Diagnostic Technologies Key Players in Central & South America
    • 11.3 Central & South America Companion Diagnostic Technologies Market Size by Type
    • 11.4 Central & South America Companion Diagnostic Technologies Market Size by Application
  • 12 International Players Profiles
    • 12.1 Dako (Agilent Technologies)
      • 12.1.1 Dako (Agilent Technologies) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Companion Diagnostic Technologies Introduction
      • 12.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.1.5 Dako (Agilent Technologies) Recent Development
    • 12.2 Qiagen
      • 12.2.1 Qiagen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Companion Diagnostic Technologies Introduction
      • 12.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.2.5 Qiagen Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Companion Diagnostic Technologies Introduction
      • 12.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Abbott Laboratories
      • 12.4.1 Abbott Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Companion Diagnostic Technologies Introduction
      • 12.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.4.5 Abbott Laboratories Recent Development
    • 12.5 Ventana Medical Systems
      • 12.5.1 Ventana Medical Systems Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Companion Diagnostic Technologies Introduction
      • 12.5.4 Ventana Medical Systems Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.5.5 Ventana Medical Systems Recent Development
    • 12.6 bioMerieux
      • 12.6.1 bioMerieux Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Companion Diagnostic Technologies Introduction
      • 12.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.6.5 bioMerieux Recent Development
    • 12.7 Myriad Genetics
      • 12.7.1 Myriad Genetics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Companion Diagnostic Technologies Introduction
      • 12.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.7.5 Myriad Genetics Recent Development
    • 12.8 Resonance Health Ltd.
      • 12.8.1 Resonance Health Ltd. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Companion Diagnostic Technologies Introduction
      • 12.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.8.5 Resonance Health Ltd. Recent Development
    • 12.9 Leica Microsystems
      • 12.9.1 Leica Microsystems Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Companion Diagnostic Technologies Introduction
      • 12.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.9.5 Leica Microsystems Recent Development
    • 12.10 Life Technologies
      • 12.10.1 Life Technologies Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Companion Diagnostic Technologies Introduction
      • 12.10.4 Life Technologies Revenue in Companion Diagnostic Technologies Business (2014-2019)
      • 12.10.5 Life Technologies Recent Development
  • 13 Market Forecast 2019-2025
    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)
  • 14 Analyst’s Viewpoints/Conclusions
  • 15 Appendix
    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
        • 15.1.1.1 Research Programs/Design
        • 15.1.1.2 Market Size Estimation
        • 12.1.1.3 Market Breakdown and Data Triangulation
      • 15.1.2 Data Source
        • 15.1.2.1 Secondary Sources
        • 15.1.2.2 Primary Sources
    • 15.2 Disclaimer
    • 15.3 Author Details

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers